EVAX Evaxion
NEUTRAL
Impact: 2/10
PRESS-RELEASE
Press release: announcement
Latest settled — T+20d
EVAX ▲ +11.25% at T+20d
NEUTRAL call ✓ call won +11.25% · α vs SPY +3.63% · entry $4.00 → $4.45
Currently $3.64 · -9.00% from $4.00 entry
T+1d
-2.25%
call -2.25% · α -0.51%
$3.91
settled 3mo ago
T+5d
-10.25%
call -10.25% · α -8.04%
$3.59
settled 3mo ago
T+20d
+11.25%
call +11.25% · α +3.63%
$4.45
settled 8w ago
T+60d
—
call — · α —
—
tomorrow
Price Chart
Loading chart...
Executive Summary
Evaxion announced the convening of its Annual General Meeting on April 16, 2026, to be held at its headquarters in Denmark. The filing contains no material financial updates or operational developments, only administrative details about the meeting.
Actionable Insight
No immediate trading implications. Traders should monitor for any unexpected disclosures during or after the AGM, though such events are typically routine for clinical-stage biotechs like Evaxion.
Key Facts
- Annual General Meeting scheduled for April 16, 2026, at 14:00 CET
- Meeting to be held at Evaxion's offices in Hørsholm, Denmark
- Agenda and proposals available on the company’s investor relations website
- No financial results, guidance, or material corporate updates disclosed
Financial Impact
No financial impact disclosed
Risk Factors
- Lack of near-term catalysts; company remains in clinical development with no commercial revenue
- Forward-looking statements highlight risks around funding, clinical trial success, and market acceptance
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3259026 |
23 reports for EVAX
100%
Hit rate
best @ T+5▲ +22.94%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
1d ago
|
6-K
| $3.71 awaiting T+5 | awaiting T+5 | — | $3.64 (−1.89%) |
|
Jun 12, 2026
1d ago
|
Press Release
| $3.71 awaiting T+5 | awaiting T+5 | — | $3.64 (−1.89%) |
|
Jun 11, 2026
2d ago
|
6-K
| $3.72 awaiting T+5 | awaiting T+5 | — | $3.64 (−2.15%) |
|
Jun 11, 2026
2d ago
|
Press Release
| $3.72 awaiting T+5 | awaiting T+5 | — | $3.64 (−2.15%) |
|
May 12, 2026
4w ago
|
6-K
| $4.17 $4.09 | ▼ −1.92% | ▼ −2.00% | $3.64 (−12.71%) |
|
May 12, 2026
4w ago
|
Press Release
| $4.17 $4.09 | ▼ −1.92% | ▼ −2.00% | $3.64 (−12.71%) |
|
May 7, 2026
5w ago
|
6-K
| $4.07 $4.16 | ▲ +2.21% | ▲ +0.71% | $3.64 (−10.57%) |
|
May 4, 2026
5w ago
|
Press Release
| $4.57 $4.23 | ▼ −7.55% | ▼ −10.49% | $3.64 (−20.35%) |
|
Apr 27, 2026
6w ago
|
6-K
| $4.18 $4.57 | ▲ +9.33% | ▲ +8.93% | $3.64 (−12.92%) |
|
Apr 27, 2026
6w ago
|
Press Release
| $4.18 $4.57 | ▲ +9.33% | ▲ +8.93% | $3.64 (−12.92%) |
Showing 10 of 23
US Market Status
Market Closed — Opens Mon (47h 27m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access